Allergology International

Allergology International is the quarterly open-access journal of the Japanese Society of Allergology, published by Elsevier on the society's behalf, established in 1996, and devoted to the etiology, diagnosis and treatment of allergic and related diseases, with a 2025 Journal Impact Factor of 6.2.《国际变态反应学》（Allergology International）是日本变态反应学会的季刊，由爱思唯尔代表学会出版，创刊于 1996 年，专注变态反应及相关疾病的病因、诊断与治疗，2025 年期刊影响因子为 6.2。

Scope

• The journal publishes original papers on the etiology, diagnosis and treatment of allergic and related diseases.期刊发表关于变态反应及相关疾病病因、诊断与治疗的原创论文。
• Methods of controlling allergic reactions are treated as a subject in their own right.控制变态反应的方法被作为独立主题对待。
• Human and animal models of hypersensitivity fall within scope, spanning mechanistic and translational work.人类与动物的超敏反应模型也在范围之内，涵盖机制性与转化性研究。
• Basic and applied clinical allergy is read in the broadest sense, from molecular immunology to bedside management.基础与临床应用变态反应学按最宽泛的意义理解，从分子免疫学到临床处置。
• Three categories of manuscript are accepted: Original Articles, Review Articles and Letters to the Editor.接收三类稿件：原创论文、综述论文与读者来信。
• Thematic review series recur, with recent collections on childhood asthma, biologics for severe asthma, atopic dermatitis and urticaria.期刊常设专题综述系列，近期专辑涉及儿童哮喘、重症哮喘的生物制剂、特应性皮炎与荨麻疹。
• It stands eighth among 40 titles in Allergy and holds a first-quartile place in Immunology as well.期刊在变态反应类 40 种期刊中排第 8 位，在免疫学类同样位列第一区。

History

• The society launched the title in 1996 as its English-language journal, and the first volume carried the number 45, continuing the sequence of Japanese Journal of Allergology.学会于 1996 年创办这本英文会刊，首卷编号为第 45 卷，沿用《日本变态反应学杂志》（Japanese Journal of Allergology）的卷次。
• Publication is handled by Elsevier on behalf of the society, and authors transfer copyright to the Japanese Society of Allergology.出版事务由爱思唯尔代表学会承担，作者将版权转让给日本变态反应学会。
• The journal is fully open access under CC BY-NC-ND, and the society covers the JPY 256,000 article publishing charge for every article in the 2026 to 2028 issues.期刊为完全开放获取，采用 CC BY-NC-ND 许可，2026 至 2028 年各期文章的 25.6 万日元出版费全部由学会承担。
• Four issues appear each year, volume 75 is published in 2026, and about 86 papers were registered in 2025.每年出版四期，2026 年为第 75 卷，2025 年登记论文约 86 篇。
• The impact factor moved from 5.836 in 2021 to 7.478 in 2022, then 6.7 in 2024 and 6.2 in 2025.影响因子从 2021 年的 5.836 升至 2022 年的 7.478，2024 年为 6.7，2025 年为 6.2。
• The title is indexed in Science Citation Index Expanded and Scopus.期刊被科学引文索引扩展版与 Scopus 收录。

Editors

• Atsuhito Nakao, professor in the Department of Immunology at the University of Yamanashi, is Editor-in-Chief.主编为山梨大学免疫学系教授 Atsuhito Nakao。
• The board numbers 47 editors from 11 countries and regions, 26 of them based in Japan and eight in the United States.编委会共有来自 11 个国家和地区的 47 位编委，其中 26 位在日本，8 位在美国。
• International members include Cezmi A. Akdis of the Swiss Institute of Allergy and Asthma Research, Stephen J. Galli of Stanford University and Stephen T. Holgate of the University of Southampton.国际编委包括瑞士变态反应与哮喘研究所的 Cezmi A. Akdis、斯坦福大学的 Stephen J. Galli 与南安普顿大学的 Stephen T. Holgate。
• Thomas Bieber of the University Hospital Bonn, Parameswaran Nair of McMaster University and Anna Nowak-Wegrzyn of New York University also sit on the board.波恩大学附属医院的 Thomas Bieber、麦克马斯特大学的 Parameswaran Nair 与纽约大学的 Anna Nowak-Wegrzyn 亦在编委之列。
• An advisory committee brings in Jean Bousquet of Montpellier, Thomas Platts-Mills of the University of Virginia and Johannes Ring of Munich.顾问委员会包括蒙彼利埃的 Jean Bousquet、弗吉尼亚大学的 Thomas Platts-Mills 与慕尼黑的 Johannes Ring。
• Manuscripts are peer reviewed by two anonymous reviewers and the editor, and Kenta Horimukai of the Jikei University Katsushika Medical Center serves as social media editor.稿件由两位匿名审稿人与编辑共同评审，社交媒体编辑由东京慈惠会医科大学葛饰医疗中心的 Kenta Horimukai 担任。